Lv1
10 积分 2026-03-15 加入
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
2个月前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
2个月前
已完结
Harnessing chimeric antigen receptor macrophages against solid tumors
2个月前
已完结
Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies
2个月前
已完结
Chimeric antigen receptor T cell therapy for autoimmune disease
2个月前
已完结
Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration
2个月前
已关闭
The druggable genome
3个月前
已完结
CRISPR technologies for genome, epigenome and transcriptome editing
3个月前
已完结
WNT–β-catenin signalling in hepatocellular carcinoma: from bench to clinical trials
3个月前
已完结
Improving surgical treatments for hepatocellular carcinoma
3个月前
已完结
皖公网安备34019202002308
